Fidelity International’s 1Life Healthcare ONEM Stock Holding History

Fidelity International’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,174,014	Closed	-$137M	–	886
2022 Q4	$137M	Buy	8,174,014 +371,528	+5%	+$6.28M	0.16%	158
2022 Q3	$134M	Buy	+7,802,486	New	+$122M	0.17%	148
2022 Q1	–	Sell	-650,000	Closed	-$11.4M	–	889
2021 Q4	$11.4M	Sell	650,000 -921,967	-59%	-$17.9M	0.01%	524
2021 Q3	$31.8M	Buy	1,571,967 +40,254	+3%	+$1.03M	0.04%	367
2021 Q2	$50.6M	Buy	1,531,713 +232,905	+18%	+$8.79M	0.05%	304
2021 Q1	$50.8M	Buy	1,298,808 +34,250	+3%	+$1.61M	0.06%	283
2020 Q4	$55.2M	Sell	1,264,558 -3,784,752	-75%	-$129M	0.07%	268
2020 Q3	$143M	Buy	5,049,310 +777,744	+18%	+$24.6M	0.18%	150
2020 Q2	$155M	Buy	4,271,566 +2,125,089	+99%	+$59.9M	0.21%	118
2020 Q1	$39M	Buy	+2,146,477	New	+$47.1M	0.06%	260

Fidelity International's ONEM Position: Q1 2023 in Review

Fidelity International sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 8,174,014 shares — an estimated $137M sold.

Fidelity International first reported a position in ONEM in Q1 2020 and held it in 10 quarters. The position peaked at $155M in Q2 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Fidelity International reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Fidelity International sold 8,174,014 1Life Healthcare shares in Q1 2023, an estimated $137M.
Fidelity International first reported a position in 1Life Healthcare in Q1 2020 and held it in 10 quarters.
Fidelity International's 1Life Healthcare position peaked at $155M in Q2 2020.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Fidelity International's 13F filing for Q1 2023, filed 11 May 2023.